Runx1 Is Required for Cbfb-MYH11 Activity During Primitive Hematopoiesis

被引：0
|
作者：
Hyde, R. Katherine [1 ]
Zhao, Ling [1 ]
Alemu, Lemlem [1 ]
Liu, Pu Paul [1 ]
机构：
[1] NHGRI, NIH, Bethesda, MD 20892 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：596 / 596
页数：1
相关论文
共 50 条
  • [31] A Runx1-Smad6 Rheostat Controls Runx1 Activity during Embryonic Hematopoiesis
    Knezevic, Kathy
    Bee, Thomas
    Wilson, Nicola K.
    Janes, Mary E.
    Kinston, Sarah
    Polderdijk, Stephanie
    Kolb-Kokocinski, Anja
    Ottersbach, Katrin
    Pencovich, Niv
    Groner, Yoram
    de Bruijn, Marella
    Goettgens, Berthold
    Pimanda, John E.
    MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (14) : 2817 - 2826
  • [32] CBFB-MYH11/RUNX1 TOGETHER WITH A COMPENDIUM OF HEMATOPOIETIC REGULATORS, CHROMATIN MODIFIERS AND BASAL TRANSCRIPTION FACTORS OCCUPIES SELF-RENEWAL GENES IN INV(16) ACUTE MYELOID LEUKEMIA
    Martens, Joost
    Mandoli, Amit
    Singh, Abhishek
    Jansen, Pascal
    Wierenga, Bart-Jan
    Riahi, Human
    Franci, Gianluigi
    Prange, Koen
    Saeed, Sadia
    Vellenga, Edo
    Vermeulen, Michiel
    Stunnenberg, Henk
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) : S50 - S50
  • [33] CBFB-MYH11/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv(16) acute myeloid leukemia
    Mandoli, A.
    Singh, A. A.
    Jansen, P. W. T. C.
    Wierenga, A. T. J.
    Riahi, H.
    Franci, G.
    Prange, K.
    Saeed, S.
    Vellenga, E.
    Vermeulen, M.
    Stunnenberg, H. G.
    Martens, J. H. A.
    LEUKEMIA, 2014, 28 (04) : 770 - 778
  • [34] Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia
    Castilla, LH
    Perrat, P
    Martinez, NJ
    Landrette, SF
    Keys, R
    Oikemus, S
    Flanegan, J
    Heilman, S
    Garrett, L
    Dutra, A
    Anderson, S
    Pihan, GA
    Wolff, L
    Liu, PP
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (14) : 4924 - 4929
  • [35] Clinical Impact of Minimal Residual Disease (MRD) Monitoring in AML with PM-Rara, CBFB-MYH11, and RUNX1-RUNX1T1: A Study on 600 Patients
    Haferlach, Torsten
    Meggendorfer, Manja
    Schnittger, Susanne
    Fasan, Annette
    Kern, Wolfgang
    Haferlach, Claudia
    BLOOD, 2015, 126 (23)
  • [36] Rapid CBFB-MYH11 diagnosis by one single MYH11 real-time PCR.
    Van der Reijden, BA
    Massop, M
    van de Locht, L
    De Witte, T
    Muus, P
    Jansen, JH
    BLOOD, 2002, 100 (11) : 327A - 328A
  • [37] Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias
    Ommen, Hans Beier
    Schnittger, Susanne
    Jovanovic, Jelena V.
    Ommen, Ingrid Beier
    Hasle, Henrik
    Ostergaard, Mette
    Grimwade, David
    Hokland, Peter
    BLOOD, 2010, 115 (02) : 198 - 205
  • [38] KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice
    Zhao, Ling
    Melenhorst, Jan J.
    Alemu, Lemlem
    Kirby, Martha
    Anderson, Stacie
    Kench, Maggie
    Hoogstraten-Miller, Shelley
    Brinster, Lauren
    Kamikubo, Yasuhiko
    Gilliland, D. Gary
    Liu, P. Paul
    BLOOD, 2012, 119 (06) : 1511 - 1521
  • [39] Oncogenes PLAG1 and PLAGL2 synergize with CBFB-MYH11 in AML.
    Landrette, S
    Perrat, P
    Hensen, K
    de Ven, V
    Castilla, L
    BLOOD, 2002, 100 (11) : 85A - 85A
  • [40] Distinct Roles of GATA2 in Development and Evolution of CBFB-MYH11 AML
    Saida, Satoshi
    Zhen, Tao
    Kwon, Erika Mijin
    Lopez, Guadalupe
    Liu, Paul P.
    BLOOD, 2018, 132
12345